armgo.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.armgo.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Home - |
| Description | First-in-Class Disease-Modifying Therapeutics in Rare Cardiac and Skeletal Muscle About Team Research Pipeline Clinical Trials News Contact First-in-Class Disease-Modifying Therapeutics in Rare Cardiac and Skeletal Muscle Diseases Lates |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 206.188.192.205 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
armgo.com Valuation
|
US$3,650,973
Last updated: 2023-05-09 22:39:51
armgo.com has Semrush global rank of 2,899,037. armgo.com has an estimated worth of US$ 3,650,973, based on its estimated Ads revenue. armgo.com receives approximately 421,267 unique visitors each day. Its web server is located in United States, with IP address 206.188.192.205. According to SiteAdvisor, armgo.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,650,973 |
| Daily Ads Revenue | US$3,371 |
| Monthly Ads Revenue | US$101,104 |
| Yearly Ads Revenue | US$1,213,247 |
| Daily Unique Visitors | 28,085 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| armgo.com. | A | 7200 | IP: 206.188.192.205 |
| armgo.com. | NS | 7200 | NS Record: ns96.worldnic.com. |
| armgo.com. | NS | 7200 | NS Record: ns95.worldnic.com. |
| armgo.com. | MX | 7200 | MX Record: 10 east.smtp.mx.exch084.serverdata.net. |
| armgo.com. | MX | 7200 | MX Record: 20 west.smtp.mx.exch084.serverdata.net. |
HtmlToTextCheckTime:2023-05-09 22:39:51
| About Team Research Pipeline Clinical Trials News Contact First-in-Class Disease-Modifying Therapeutics in Rare Cardiac and Skeletal Muscle Diseases Latest News ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases 12.20.21 Read More ARMGO Pharma’s mission is to use rigorous science to develop novel small molecule drugs that repair calcium channels to help patients in need Company Summary ARMGO is a privately owned, venture-backed, biotech company that is developing small molecule drugs that repair leaky Ryanodine Receptor (RyR) calcium channels associated with human diseases. We hold an exclusive, worldwide license from Columbia University for its RyR technology and know-how. Our primary focus is on two orphan diseases: the life-threatening cardiac disease Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), and the severe muscle disease RYR1-Related Myopathy (RYR1-RM). These two conditions occur due to |
HTTP Headers
HTTP/1.1 200 OK Server: openresty/1.17.8.2 Date: Mon, 01 Nov 2021 16:43:07 GMT Content-Type: text/html Content-Length: 40766 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Wed, 13 May 2020 18:13:22 GMT ETag: "9f3e-5a58b89165075" X-Webcom-Cache-Status: BYPASS Accept-Ranges: bytes |
armgo.com Whois Information
Domain Name: ARMGO.COM Registry Domain ID: 195372560_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-06-12T08:11:45Z Creation Date: 2005-08-11T18:39:57Z Registry Expiry Date: 2022-08-11T18:39:57Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS95.WORLDNIC.COM Name Server: NS96.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T01:26:01Z <<< |